EUVIMEDEUVIMED entdecken
Open Access

Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer

Matt Church iD, George Burghel iD, Guy Betts, Steven Michael Churchill, Helene Barbara Schlecht, Yatin Jain, Kevin Harrington iD, Robert Metcalf

JCO Precision Oncology · 2025-10 · (9)

DOI: 10.1200/po-25-00490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2025-10. Verfasst von Matt Church und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Christie NHS Foundation Trust, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Precision Medicine, Salivary Gland Neoplasms, Whole Genome Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Salivary gland cancers (SGCs) are rare and comprise multiple histologic entities. In the recurrent or metastatic (R/M) setting, there is limited evidence for effective systemic anticancer treatment for most subtypes, affecting prognosis and quality of life. Molecular analysis of SGCs holds promise to more accurately classify SGC subtypes and to determine novel therapeutic targets. MATERIALS AND METHODS Fifteen patients with R/M SGC underwent tumor biopsy and blood sampling to perform whole-genome sequencing (WGS) of tumor and germline as part of their standard-of-care management. Small somatic mutations, structural alterations, copy number variation, and mutational signatures were processed using WGS pipelines alongside germline testing. Alterations were correlated to clinical features and fed back to clinical team to inform treatment decisions. RESULTS WGS quality control was acceptable in 14 of 15 patients (adenoid cystic carcinoma [AdCC, n = 10], salivary duct carcinoma ex pleomorphic adenoma [n = 1]; clear cell myoepithelial carcinoma [n = 1]; epithelial-myoepithelial carcinoma [n = 1]; and acinic cell carcinoma [n = 1]). Genomic rearrangements/fusions were present in 12 of 14. Rearrangements involving MYB and or NFIB were identified in 8 of 10 patients with AdCC. One patient harbored a clinically actionable FGFR1 - pleomorphic adenoma gene 1 fusion and responded to fibroblast growth factor receptor–targeted therapy, in addition to enabling histologic reclassification. Other fusions included EWSR1 - ATF1 and CRTC1 - MAML2 , which also aided definitive histologic classification. Small somatic alterations were identified in all but one patient. There were no pathogenic germline mutations. CONCLUSION WGS in SGC is achievable in clinically relevant timeframes, providing genomic information for deeper understanding of disease pathophysiology, to clarify histologic subtype and can identify actionable genomic targets which may not be found through routine sequencing technologies. Further use of WGS has the potential to improve care for patients with SGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineSalivary Gland NeoplasmsWhole Genome SequencingHumansMaleFemaleMiddle AgedAgedAdultMutation

Autor:innen und Institutionen

  • The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • The University of Manchester, Manchester, United Kingdom.
  • Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • The Institute of Cancer Research, London, United Kingdom.

ORCID-Profile: Matt Church, George Burghel, Kevin Harrington

Zitieren

APA

Church, M., Burghel, G., Betts, G., Churchill, S. M., Schlecht, H. B., Jain, Y., Harrington, K., & Metcalf, R. (2025). Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer. JCO Precision Oncology. https://doi.org/10.1200/po-25-00490

Vancouver

Church M, Burghel G, Betts G, Churchill SM, Schlecht HB, Jain Y, et al. Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer. JCO Precision Oncology. 2025. doi:10.1200/po-25-00490

BibTeX
@article{Church2025,
  author = {Church, Matt and Burghel, George and Betts, Guy and Churchill, Steven Michael and Schlecht, Helene Barbara and Jain, Yatin and Harrington, Kevin and Metcalf, Robert},
  title = {Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer},
  journal = {JCO Precision Oncology},
  year = {2025},
  number = {9},
  doi = {10.1200/po-25-00490}
}
Kostenlos starten →